REQUEST A DEMO
Total
USD $0.00
Search more companies

Heromycin Pharma Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Heromycin Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Heromycin Pharma Company Limited is an enterprise based in Thailand. Its main office is in Bangkok , Special Governed District of. The company operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 30, 2026. 53 (2024) employees currently work for Heromycin Pharma Company Limited. The company’s latest financial report indicates a net sales revenue increase of 8.49% in 2024. Its total assets decreased by 5.73% over the same period. The net profit margin of Heromycin Pharma Company Limited increased by 23.36% in 2024.

Headquarters
537/2,537/263 Sathu Pradit Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10120

Contact Details: Purchase the Heromycin Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Heromycin Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the Heromycin Pharma Company Limited report to view the information.
Incorporation Date:
May 30, 2026
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Heromycin Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
8.49%
Total Operating Revenue
8.77%
Operating Profit
37.56%
EBITDA
37.56%
Net Profit/Loss for the Period
30.27%
Total Assets
-5.73%
Total Equity
-36.39%
Operating Profit Margin
24.31%
Net Profit Margin
23.36%
Return on Equity (ROE)
-25.51%
Debt / Equity
-129.59%
Quick Ratio
0.51%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?